Ashton Thomas Private Wealth’s Idexx Laboratories IDXX Stock Holding History

Ashton Thomas Private Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$296K	Sell	562 -9	-2%	-$5.05K	0.01%	993
2026 Q1	$321K	Buy	571 +97	+20%	+$62.2K	0.01%	861
2025 Q4	$321K	Buy	474 +82	+21%	+$55.8K	0.01%	799
2025 Q3	$250K	Buy	+392	New	+$238K	0.01%	856
2024 Q3	–	Sell	-182	Closed	-$88.7K	–	1194
2024 Q2	$88.7K	Buy	+182	New	+$91.4K	﹤0.01%	784
2024 Q1	–	Sell	-475	Closed	-$264K	–	606
2023 Q4	$264K	Sell	475 -207	-30%	-$97.2K	0.02%	514
2023 Q3	$298K	Sell	682 -56	-8%	-$27.9K	0.02%	475
2023 Q2	$371K	Sell	738 -99	-12%	-$47.4K	0.03%	449
2023 Q1	$419K	Buy	837 +134	+19%	+$64.1K	0.04%	383
2022 Q4	$287K	Buy	+703	New	+$273K	0.03%	407

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Ashton Thomas Private Wealth's IDXX Position: Q2 2026 in Review

Ashton Thomas Private Wealth reduced its Idexx Laboratories (IDXX) stake by 1.6% in Q2 2026, selling an estimated $5.05K and leaving 562 shares worth $296K. The position accounts for 0.01% of the portfolio, ranked #993.

Ashton Thomas Private Wealth first reported a position in IDXX in Q4 2022 and has held it in 10 quarters since. The position peaked at $419K in Q1 2023. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Ashton Thomas Private Wealth held 562 shares of Idexx Laboratories worth $296K as of Q2 2026.
Ashton Thomas Private Wealth sold 9 Idexx Laboratories shares in Q2 2026, an estimated $5.05K.
Idexx Laboratories made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #993 holding.
Ashton Thomas Private Wealth first reported a position in Idexx Laboratories in Q4 2022 and has held it in 10 quarters since.
Ashton Thomas Private Wealth's Idexx Laboratories position peaked at $419K in Q1 2023.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.